21 Hrs
المصدر:
الاقتصادية
الاقتصادية
جاهز للتشغيل
جاهز للتشغيل
A federal judge in Delaware has rejected Bayer's requests to dismiss patent infringement lawsuits filed against it by Monsanto, related to the use of mRNA technology in COVID-19 vaccines. The judge confirmed that vaccine manufacturers have not yet proven that the patents are invalid or that their rights are being infringed upon. Bayer stated that patented innovations have been used without authorization, while the vaccine companies argued that they are working with different technologies and dismissed the patents as laws of nature. Other lawsuits between Bayer and companies such as Johnson & Johnson are still ongoing.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading